CELLF BIO Achieves Milestone With First In Human Implantation of BioSphincter™ CELLF BIO Achieves Milestone With First In Human Implantation of BioSphincter™
ZielBio to Present Interim Findings from its Phase 1/2, First-in-Human Trial of ZB131 at 2023 ASCO Annual Meeting ZielBio to Present Interim Findings from its Phase 1/2, First-in-Human Trial of ZB131 at 2023 ASCO Annual Meeting
Unintended consequences - FODMAP rich diets and digestive distress Unintended consequences - FODMAP rich diets and digestive distress
Virginia Catalyst Awards $2 Million in Grants to Support Life Sciences in the Commonwealth Virginia Catalyst Awards $2 Million in Grants to Support Life Sciences in the Commonwealth
Springbok Analytics raises $3 million seed round for their AI-powered platform that converts MRIs into 3D analysis of muscles Springbok Analytics raises $3 million seed round for their AI-powered platform that converts MRIs into 3D analysis of muscles
CraniUS and Medical Product Laboratories Partner for Device-Based Drug Delivery CraniUS and Medical Product Laboratories Partner for Device-Based Drug Delivery
How NextCure is Approaching Women’s Cancers Differently: Perspectives from Three Scientists How NextCure is Approaching Women’s Cancers Differently: Perspectives from Three Scientists
NImmune Biopharma Launches with Phase III-Ready Asset Gained from Landos Biopharma NImmune Biopharma Launches with Phase III-Ready Asset Gained from Landos Biopharma
Focused Ultrasound Improves Liquid Biopsy Results in an Alzheimer’s Disease Model Focused Ultrasound Improves Liquid Biopsy Results in an Alzheimer’s Disease Model
